ISOTECHNIKA GETS PATENT FOR ISA247

Isotechnika has been issued U.S. Patent No. 6,998,385 for mixtures of cis- and trans-isomers of its lead immunosuppressive drug, ISA247.

ISA247 is an immunosuppressant currently in an extension protocol of a Phase III human clinical trial for the treatment of moderate-to-severe psoriasis. In addition, ISA247 has successfully completed a Phase IIa trial for kidney transplantation.